238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
24.98%
Revenue growth of 24.98% while BIDU is flat. Bruce Berkowitz would check if a small edge can widen further.
21.12%
Gross profit growth of 21.12% while BIDU is zero. Bruce Berkowitz would see if minimal improvements could expand further.
23.28%
EBIT growth of 23.28% while BIDU is zero. Bruce Berkowitz would see if small gains can be scaled further.
23.28%
Operating income growth of 23.28% while BIDU is zero. Bruce Berkowitz would see if this modest edge can become significant.
23.72%
Net income growth of 23.72% while BIDU is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
-11.54%
Negative EPS growth while BIDU is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.54%
Negative diluted EPS growth while BIDU is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
38.33%
Share change of 38.33% while BIDU is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
40.71%
Diluted share change of 40.71% while BIDU is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-43.36%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-60.24%
Negative FCF growth while BIDU is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
152.68%
10Y CAGR of 152.68% while BIDU is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
152.68%
5Y CAGR of 152.68% while BIDU is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
152.68%
3Y CAGR of 152.68% while BIDU is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.38%
10Y net income/share CAGR of 21.38% while BIDU is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
21.38%
Net income/share CAGR of 21.38% while BIDU is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
21.38%
3Y net income/share CAGR of 21.38% while BIDU is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-45.34%
Our R&D shrinks while BIDU invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-100.00%
We cut SG&A while BIDU invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.